The purpose of this study was to determine whether FAK expression in the endothelial cell or tumour cell compartment of invasive breast carcinomas correlates with established clinicopathological characteristics, or differences between molecular sub-types. This evidence concerns the gene PTK2 and invasive breast carcinoma.